No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs558450450 |
chr2:98856555-98856556 |
Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs575065019 |
chr2:98856556-98856557 |
Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs376262074 |
chr2:98856690-98856691 |
Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs544016503 |
chr2:98856691-98856692 |
Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs150282857 |
chr2:98856784-98856785 |
Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs189871525 |
chr2:98856785-98856786 |
Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs570129763 |
chr2:98856792-98856793 |
Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs539998431 |
chr2:98856822-98856823 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs560084233 |
chr2:98856823-98856824 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs532044605 |
chr2:98856839-98856840 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs138888029 |
chr2:98856852-98856853 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs149406746 |
chr2:98856869-98856870 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs10170356 |
chr2:98856881-98856882 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
14 |
rs548811306 |
chr2:98856938-98856939 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs568416639 |
chr2:98856941-98856942 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs62156686 |
chr2:98856960-98856961 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
17 |
rs11891512 |
chr2:98857001-98857002 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
18 |
rs570812023 |
chr2:98857048-98857049 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs539466927 |
chr2:98857055-98857056 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs6731804 |
chr2:98857060-98857061 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
21 |
rs116439733 |
chr2:98857089-98857090 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs145823669 |
chr2:98857132-98857133 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs138746711 |
chr2:98857185-98857186 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs574586153 |
chr2:98857207-98857208 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs540307611 |
chr2:98857239-98857240 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs532282125 |
chr2:98857261-98857262 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs560018630 |
chr2:98857280-98857281 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs550450244 |
chr2:98857377-98857378 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs142680474 |
chr2:98857385-98857386 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs563136230 |
chr2:98857445-98857446 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs371697331 |
chr2:98857464-98857465 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs553054744 |
chr2:98857466-98857467 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs532048571 |
chr2:98857469-98857470 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs4455212 |
chr2:98857601-98857602 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
35 |
rs568632938 |
chr2:98857605-98857606 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs138033148 |
chr2:98857619-98857620 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs181628296 |
chr2:98857623-98857624 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs547837660 |
chr2:98857637-98857638 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs537722564 |
chr2:98857712-98857713 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs72950941 |
chr2:98857770-98857771 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
41 |
rs557004632 |
chr2:98857822-98857823 |
Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs62156687 |
chr2:98857886-98857887 |
Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
43 |
rs4535095 |
chr2:98857893-98857894 |
Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
44 |
rs36102785 |
chr2:98857976-98857977 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
45 |
rs537738847 |
chr2:98857979-98857980 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs554600720 |
chr2:98857987-98857988 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs574553021 |
chr2:98858102-98858103 |
Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs560772994 |
chr2:98858122-98858123 |
Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs76868564 |
chr2:98858136-98858137 |
Enhancers Flanking Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs553405586 |
chr2:98858137-98858138 |
Enhancers Flanking Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|